Ignite Creation Date:
2025-12-26 @ 1:17 PM
Ignite Modification Date:
2026-01-01 @ 1:07 AM
Study NCT ID:
NCT06924606
Status:
RECRUITING
Last Update Posted:
2025-09-30
First Post:
2025-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Sponsor:
Shanghai Junshi Bioscience Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-26
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-06
First Submit QC Date:
None
Study First Post Date:
2025-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-24
Last Update Post Date:
2025-09-30
Last Update Post Date Type:
ESTIMATED